ACTRN12617001273370招募中3 期
Rapid ferric carboxymaltose infusion (Ferinject) for Iron Deficiency Anaemia in Aboriginal children: a randomised controlled trial
适应症
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 入组人数
- 226
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- o limit 至 6 Years（—）
- 性别
- All
入选标准
- •Aboriginal or Torres Strait Islander children with Iron deficiency anaemia (a haemoglobin level (Hb) <110g/L and mean cell volume (MCV) <75fL), will be eligible to participate in the randomised trial if the treating clinician recommends parenteral iron treatment.
排除标准
- •1) parenteral iron treatment or blood transfusion within the last 4 weeks; 2) known iron overload, haemoglobinopathy, haemolytic anaemia, aplastic anaemia, lymphoproliferative disease or current cancer treatment; 3) febrile >38 degree centigrade or very unwell or receiving phosphate supplementation at the time of discharge; 4) lack of access to a primary health provider in the NT; 5) allergy or hypersensitivity to Ferinject or any of its excipients; 6) known serious hypersensitivity to other parenteral iron products; 7) severe asthma, eczema or allergies; 8) not planning to remain resident in the NT for 12 months.
研究者
相似试验
进行中（未招募）
不适用
Intravenous ferric carboxymaltose (Ferinject®) with or without Erythropoietin for the correction of preoperative anaemia in patients undergoing orthopaedic surgery•To evaluate the effect of the administration of ferric carboxymaltose (Ferinject®) with or without erythropoietin vs. no treatment (standard therapy) on the preoperative anaemia status in patients undergoing orthopaedic surgery •To gain informations for the design of a possible follow-up study•.•To evaluate the tolerability and safety of Ferinject®EUCTR2009-015799-92-ATniversitätspital Zürich Anästhesie75
招募中
4 期
Iron infusion in iron-deficient patients undergoing surgery for colorectal cancer who are anaemic versus not anaemic in order to improve physical fitness as determined by exercise testing and a quality of life questionnaire.Iron deficiencyAnaemiaCancer - Bowel - Back passage (rectum) or large bowel (colon)Anaesthesiology - Other anaesthesiologyBlood - AnaemiaColorectal CancerACTRN12616001219471Peter MacCallum Cancer Centre36
已完成
不适用
Efficacy and safety of Ferric carboxymaltose injection compared with oral iron for the treatment of postpartum anemia in Japan: a randomized controlled clinical trialpostpartum anemiaJPRN-UMIN000046049Jikei university school of medicine60
进行中（未招募）
不适用
Intravenöse Eisencarboxymaltose-Applikation zur Verbesserung der metabolischen Parameter und der Gefäßfunktion bei Diabetes mellitus Typ 2-Patienten für 12 Wochen (Clever-Studie)patients with diabetes mellitus type 2 and iron deficiencyEUCTR2011-005224-18-DEGWT-TUD GmbH
已完成
4 期
A clinical trial to compare oral iron ferrous sulfate with newer intravenous iron (ferric carboxymaltose) injection in patients of iron deficiency anemia in post delivery periodCTRI/2014/10/005099CMS and GTB Hospital140